This Article Full Text Full Text (PDF) All Versions of this Article: 107/23/2920    most recent 01.CIR.0000072767.89944.6Ev1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, T. J. Articles by Benjamin, E. J. Search for Related Content PubMed PubMed Citation Articles by Wang, T. J. Articles by Benjamin, E. J. Related Collections Arrhythmias, clinical electrophysiology, drugs Epidemiology Congestive

(Circulation. 2003;107:2920.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

The Framingham Heart Study

Thomas J. Wang, MD; Martin G. Larson, ScD; Daniel Levy, MD; Ramachandran S. Vasan, MD; Eric P. Leip, MS; Philip A. Wolf, MD; Ralph B. D’Agostino, PhD; Joanne M. Murabito, MD, ScM; William B. Kannel, MD; Emelia J. Benjamin, MD, ScM

From the Framingham Heart Study (all authors), Framingham, Mass; Cardiology Division (T.J.W.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass; Sections of Cardiology (D.L., R.S.V., E.J.B.), Preventive Medicine (M.G.L., D.L., R.S.V., J.M.M., W.B.K., E.J.B.), Neurology (P.A.W.), and General Internal Medicine (J.M.M.), Boston University School of Medicine, Boston, Mass; National Heart, Lung, and Blood Institute (D.L.), Bethesda, Md; and Department of Mathematics (R.B.D.), Boston University, Boston, Mass.

Correspondence to Dr Emelia Benjamin, Framingham Heart Study, 73 Mt Wayte Ave, Suite #2, Framingham, MA 01702-5827. E-mail emelia{at}bu.edu

Background— Atrial fibrillation (AF) and congestive heart failure (CHF) frequently occur together, but there is limited information regarding their temporal relations and the combined influence of these conditions on mortality.

Methods and Results— We studied participants in the Framingham Study with new-onset AF or CHF. Multivariable Cox proportional hazards models with time-dependent variables were used to evaluate whether mortality after AF or CHF was affected by the occurrence and timing of the other condition. Hazard ratios (HRs) were adjusted for time period and cardiovascular risk factors. During the study period, 1470 participants developed AF, CHF, or both. Among 382 individuals with both conditions, 38% had AF first, 41% had CHF first, and 21% had both diagnosed on the same day. The incidence of CHF among AF subjects was 33 per 1000 person-years, and the incidence of AF among CHF subjects was 54 per 1000 person-years. In AF subjects, the subsequent development of CHF was associated with increased mortality (men: HR 2.7; 95% CI, 1.9 to 3.7; women: HR 3.1; 95% CI, 2.2 to 4.2). Similarly, in CHF subjects, later development of AF was associated with increased mortality (men: HR 1.6; 95% CI, 1.2 to 2.1; women: HR 2.7, 95% CI, 2.0 to 3.6). Preexisting CHF adversely affected survival in individuals with AF, but preexisting AF was not associated with adverse survival in those with CHF.

Conclusions— Individuals with AF or CHF who subsequently develop the other condition have a poor prognosis. Additional studies addressing the pathogenesis, prevention, and optimal management of the joint occurrence of AF and CHF appear warranted.

Key Words: arrhythmia • fibrillation, atrial • heart failure • mortality

This article has been cited by other articles:

				G.-R. Li, H.-B. Wang, G.-W. Qin, M.-W. Jin, Q. Tang, H.-Y. Sun, X.-L. Du, X.-L. Deng, X.-H. Zhang, J.-B. Chen, et al. Acacetin, a Natural Flavone, Selectively Inhibits Human Atrial Repolarization Potassium Currents and Prevents Atrial Fibrillation in Dogs Circulation, May 13, 2008; 117(19): 2449 - 2457. [Abstract] [Full Text] [PDF]